Strides Pharma Science reports consolidated net profit of Rs 142 crore in Q2FY20

25 Oct 2019 Evaluate

Strides Pharma Science has reported results for second quarter ended September 30, 2019. 

The company has reported net profit of Rs 47 crore for the quarter under review as against net loss of Rs 14.30 crore for the same quarter in the previous year. Total income of the company increased by 27.54% at Rs 457.61 crore for Q2FY20 as compared Rs 358.79 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported net profit of Rs 141.91 crore for the quarter under review as against net loss of Rs 8.70 crore for the same quarter in the previous year. Total income of the company increased by 37.51% at Rs 728.08 crore for Q2FY20 as compared Rs 529.46 crore for the corresponding quarter previous year.   

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×